Login / Signup

Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers.

Corey P FalconLarisa BroglieRachel PhelanSung W ChoiJeffery J AulettaJoseph H Chewning
Published in: Pediatric transplantation (2020)
No standardized guidelines exist for infectious prophylaxis following pediatric auto-HSCT. We hypothesized significant variation in clinical practice. Thirty-three Pediatric Transplant and Cell Therapy Consortium centers completed a survey to assess institutional management. The majority utilize viral (91%) and fungal prophylaxis (94%), but duration varies. Bacterial prophylaxis during neutropenia is instituted by 42%. Our study demonstrates marked practice variability in infectious prophylaxis across centers. Additional research is needed to address patterns of infectious complications and to develop meaningful clinical practice guidelines for pediatric auto-HSCT.
Keyphrases
  • cell therapy
  • clinical practice
  • stem cells
  • mesenchymal stem cells
  • primary care
  • sars cov
  • acute myeloid leukemia
  • bone marrow
  • young adults
  • quality improvement
  • hematopoietic stem cell